CoreAge Rx
Low advertised entry prices across GLP-1 and wellness programs. The final commitment and consultation refund terms need a close read.
Read our review →14 source-backed reviews
Provider terms, product details, open questions. Every review explains what the public record can—and cannot—establish.
Low advertised entry prices across GLP-1 and wellness programs. The final commitment and consultation refund terms need a close read.
Read our review →A straightforward recurring price with a much cheaper prepaid starter offer. The first three months and the fourth month are different purchases.
Read our review →Medication and membership are separate. Dose-dependent starting prices need both numbers before they resemble a monthly budget.
Read our review →Longer commitments create a large gap between an advertised monthly equivalent and the standard recurring program price.
Read our review →FDA-approved medication access with a separate care membership. The medicine-only number is one component of the bill.
Read our review →Several wellness routes with first-month promotions. The ongoing price and upfront billing period deserve equal attention.
Read our review →Public injection and lozenge prices make route-specific comparison possible; the exact prescription remains a consultation decision.
Read our review →NAD+ pricing varies by vial size and commitment. The single-month plans are a clearer baseline than the largest headline discount.
Read our review →Starting GLP-1 prices include a program fee, with a program-length commitment that needs to be settled before checkout.
Read our review →Manufacturer prices for Zepbound and Foundayo, with strength-specific offers and important refill deadlines.
Read our review →Wegovy pill and pen offers, where the dose, device and introductory period determine the advertised price.
Read our review →A clearly named copper-peptide ingredient and a retail bottle price, without a subscription.
Read our review →A lipid-rich copper-peptide balm with a stated 15 mL package. Compare the formula and quantity as well as the price.
Read our review →An FDA-approved bremelanotide product with a four-dose offer and a narrow eligibility context.
Read our review →